SG Americas Securities
VIE

SG Americas Securities’s Viela Bio, Inc. Common Stock VIE Stock Holding History

SG Americas Securities’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,107
Closed -$284K – 3545
2020
Q3 		$284K Buy
10,107
+2,638
+35% +$93.3K ﹤0.01% 1965
2020
Q2 		$324K Buy
+7,469
New +$338K ﹤0.01% 2463

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities's VIE Position: Q4 2020 in Review

SG Americas Securities sold out of Viela Bio, Inc. Common Stock (VIE) in Q4 2020, closing a stake of 10,107 shares — an estimated $284K sold.

SG Americas Securities first reported a position in VIE in Q2 2020 and held it in 2 quarters. The position peaked at $324K in Q2 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q4 2020.

  • SG Americas Securities reported no remaining Viela Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • SG Americas Securities sold 10,107 Viela Bio, Inc. Common Stock shares in Q4 2020, an estimated $284K.
  • SG Americas Securities first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • SG Americas Securities's Viela Bio, Inc. Common Stock position peaked at $324K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q4 2020.

Based on SG Americas Securities's 13F filing for Q4 2020, filed 4 Feb 2021.